0 Beoordelingen

ID

22459

Beschrijving

Study part: Investigational Product Discontinuation.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Trefwoorden

  1. 05-06-17 05-06-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

5 juni 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :


    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Investigational Product Discontinuation Mepolizumab HES NCT00086658

    Investigational Product Discontinuation

    INVESTIGATIONAL PRODUCT DISCONTINUATION
    Beschrijving

    INVESTIGATIONAL PRODUCT DISCONTINUATION

    Alias
    UMLS CUI-1
    C0013230
    UMLS CUI-2
    C0457454
    Subject ID
    Beschrijving

    Subject ID

    Datatype

    text

    Alias
    UMLS CUI [1]
    C2348585
    Was the investigational product stopped permanently before the end of the scheduled treatment period?
    Beschrijving

    Investigational Product Discontinuation

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0013230
    UMLS CUI [1,2]
    C0457454
    The primary reason the investigational product was stopped:
    Beschrijving

    Reason Investigational Product Discontinuation

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0392360
    UMLS CUI [1,2]
    C0013230
    UMLS CUI [1,3]
    C0457454
    If other, please specify
    Beschrijving

    Other

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0205394

    Similar models

    Investigational Product Discontinuation

    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    INVESTIGATIONAL PRODUCT DISCONTINUATION
    C0013230 (UMLS CUI-1)
    C0457454 (UMLS CUI-2)
    Subject ID
    Item
    Subject ID
    text
    C2348585 (UMLS CUI [1])
    Investigational Product Discontinuation
    Item
    Was the investigational product stopped permanently before the end of the scheduled treatment period?
    boolean
    C0013230 (UMLS CUI [1,1])
    C0457454 (UMLS CUI [1,2])
    Item
    The primary reason the investigational product was stopped:
    text
    C0392360 (UMLS CUI [1,1])
    C0013230 (UMLS CUI [1,2])
    C0457454 (UMLS CUI [1,3])
    Code List
    The primary reason the investigational product was stopped:
    CL Item
    Lost to follow-up (Lost to follow-up)
    C1302313 (UMLS CUI-1)
    CL Item
    Protocol violation (Protocol violation)
    C1709750 (UMLS CUI-1)
    CL Item
    Subject decided to withdraw from the study (Subject decided to withdraw from the study)
    C2348571 (UMLS CUI-1)
    CL Item
    Lack of efficacy (Lack of efficacy)
    C0235828 (UMLS CUI-1)
    CL Item
    Sponsor terminated study (Sponsor terminated study)
    C1710224 (UMLS CUI-1)
    CL Item
    Disease progression (Disease progression)
    C0242656 (UMLS CUI-1)
    CL Item
    Other, specify (Other, specify)
    C0205394 (UMLS CUI-1)
    CL Item
    Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate))
    C0877248 (UMLS CUI-1)
    Other
    Item
    If other, please specify
    text
    C0205394 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial